NEXTWAVE PHARMACEUTICALS INC

Profile

Company Names

NEXTWAVE PHARMACEUTICALS INC

Addresses

20450 STEVENS CREEK BOULEVARD, SUITE 150, CUPERTINO, CA 95014

Phone Numbers

4083421300

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$27,229,417.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2011-01-10 
$27,229,417.00 
$45,479,417.00 
$18,250,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GAURAV 
 
AGGARWAL 
DIRECTOR
HYPERION THERAPEUTICS INC   |  NEXTWAVE PHARMACEUTICALS INC   |  AUSPEX PHARMACEUTICALS, INC.   |  VIVO OPPORTUNITY FUND, L.P.   |  VIVO OPPORTUNITY CO-INVEST, L.P.   |  VIVO OPPORTUNITY CO-INVEST (W), L.P.   |  UNICYCIVE THERAPEUTICS, INC.   |  VIVO OPPORTUNITY CAYMAN FUND, L.P.   |  VIVO CAPITAL FUND X, L.P.   |  BONUM THERAPEUTICS, INC.
LINDA 
 
ARA 
EXECUTIVE OFFICER
NEXTWAVE PHARMACEUTICALS INC   |  SORBENT THERAPEUTICS INC   |  NOVASENTIS, INC.
SALLY 
 
BERRY 
EXECUTIVE OFFICER
NEXTWAVE PHARMACEUTICALS INC
MICHAEL 
 
BURDICK 
EXECUTIVE OFFICER
NEXTWAVE PHARMACEUTICALS INC   |  ADMIIN INC.
ROBERT 
 
CASALE 
DIRECTOR
NEXTWAVE PHARMACEUTICALS INC   |  MASSACHUSETTS MUTUAL VARIABLE LIFE SEPARATE ACCOUNT III   |  MASSACHUSETTS MUTUAL LIFE INSURANCE CO   |  MASSACHUSETTS MUTUAL VARIABLE ANNUITY SEPARATE ACCOUNT V   |  FIRST AID BEVERAGES, INC.   |  PLX PHARMA INC.   |  ALITAIR PHARMACEUTICALS, INC.
CRAIG 
 
CHAMBLISS 
EXECUTIVE OFFICER
NEXTWAVE PHARMACEUTICALS INC
STEVE 
 
ELMS 
DIRECTOR
CENERX BIOPHARMA INC   |  TRIA BEAUTY, INC.   |  NEXTWAVE PHARMACEUTICALS INC   |  K2 THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.   |  AJAX HEALTH II LLC
HINGGE 
 
HSU 
DIRECTOR
NEXTWAVE PHARMACEUTICALS INC   |  LIFEMINE THERAPEUTICS, INC.
FRANK 
 
KUNG 
DIRECTOR
SAGENT HOLDING CO.   |  REVANCE THERAPEUTICS, INC.   |  NEXTWAVE PHARMACEUTICALS INC   |  VIVO VENTURES VII AFFILIATES FUND, L.P.   |  VIVO CAPITAL FUND VIII, L.P.   |  VIVO CAPITAL SURPLUS FUND VIII, L.P.   |  AMYRIS, INC.   |  VIVO OPPORTUNITY FUND, L.P.   |  VIVO CAPITAL FUND IX, L.P.   |  VIVO OPPORTUNITY CO-INVEST, L.P.   |  VIVO OPPORTUNITY CO-INVEST (W), L.P.   |  VIVO INNOVATION FUND II, L.P.   |  VIVO ASIA OPPORTUNITY FUND, L.P.   |  VIVO OPPORTUNITY CAYMAN FUND, L.P.   |  VIVO CAPITAL FUND X, L.P.
ANAND 
 
MEHRA 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  VICEPT THERAPEUTICS, INC.   |  AERIE PHARMACEUTICALS INC   |  NEXTWAVE PHARMACEUTICALS INC   |  SPARK THERAPEUTICS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  FIRST AID BEVERAGES, INC.   |  SOFINNOVA VENTURE PARTNERS X, L.P.   |  MERUS N.V.   |  AMPLYX PHARMACEUTICALS, INC.
DAYTON 
 
MISFELDT 
DIRECTOR
SUNESIS PHARMACEUTICALS INC   |  NEXTWAVE PHARMACEUTICALS INC   |  ACIEX THERAPEUTICS, INC.   |  INTERLEUKIN GENETICS INC   |  TRIA BEAUTY, INC.
JAY 
 
SHEPARD 
EXECUTIVE OFFICER, DIRECTOR
NEXTWAVE PHARMACEUTICALS INC   |  BULLET BIOTECHNOLOGY, INC.   |  VERSARTIS, INC.   |  NEURORECOVERY TECHNOLOGIES, INC.   |  INOVIO PHARMACEUTICALS, INC.   |  CESSATION THERAPEUTICS, INC.
PATRICK 
 
ZENNER 
DIRECTOR
NEXTWAVE PHARMACEUTICALS INC   |  SELECTA BIOSCIENCES INC   |  CARTESIAN THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-01-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
AQUILO PARTNERS
114909